title: Monitoring of immunotherapy by measuring monocyte HLA-DR expression and stimulated TNFalpha production during sepsis after liver transplantation.
authors.forename: C
authors.initials: C
authors.lastname: Denzel
authors.forename: J
authors.initials: J
authors.lastname: Riese
authors.forename: W
authors.initials: W
authors.lastname: Hohenberger
authors.forename: G
authors.initials: G
authors.lastname: Born
authors.forename: F
authors.initials: F
authors.lastname: Köckerling
authors.forename: K
authors.initials: K
authors.lastname: Tschaikowsky
authors.forename: H B
authors.initials: HB
authors.lastname: Reith
authors.forename: T
authors.initials: T
authors.lastname: Reck
authors.forename: W
authors.initials: W
authors.lastname: Haupt
mesh_terms: D017809:Fatal Outcome; D006684:HLA-DR Antigens / Q000378:metabolism*; D006801:Humans; D007167:Immunotherapy; D007371:Interferon-gamma / Q000627:therapeutic use*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D018805:Sepsis / Q000276:immunology / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D006684:HLA-DR Antigens; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma